The Centers for Disease Control and Prevention has released an updated CDC Mpox Situation Summary warning that mpox outbreaks continue to affect several countries in 2026. Health officials say the virus remains a global public health concern, especially in parts of Central and Eastern Africa where cases linked to clade I mpox are increasing.
According to the CDC, the United States currently faces a low public health risk, although a small number of travel-related infections have been detected since late 2024. Officials are continuing surveillance efforts to quickly identify and contain any possible spread.
Global Mpox Cases Continue to Rise
The CDC reported that the global clade II mpox outbreak, which began in 2022, has resulted in more than 100,000 confirmed cases across over 120 countries. Most infections have been mild, but health experts warn that the virus can still pose serious risks to vulnerable individuals.
Public health agencies are focusing on testing, contact tracing, vaccinations, and awareness campaigns to reduce transmission rates. Experts say close physical contact remains the primary method of spread.
CDC Expands Monitoring and Prevention Efforts
The CDC continues to work with international health organizations to monitor the evolving outbreak. Travelers visiting affected regions are being advised to stay informed about symptoms and preventive measures.
Health officials also emphasized the importance of early diagnosis and vaccination for high-risk groups. Symptoms of mpox may include fever, swollen lymph nodes, fatigue, and skin rashes.
International Health Agencies Remain Alert
Global health experts say continued cooperation between countries will be essential in controlling future outbreaks. Monitoring efforts are particularly focused on regions experiencing rising infection rates and limited healthcare resources.
For more information, visit the official CDC Mpox Situation Summary page: CDC Mpox Situation Summary
Additional information is available from the World Health Organization